Neurologists, movement disorder specialists, gastroenterologists and nurses.

Global campaign following Association of the British Pharmaceutical Industry (ABPI) and US medical/legal guidelines.

Patients with Parkinson’s disease (PD) are treated with oral levodopa but in time it loses its effectiveness and their disease becomes advanced. Patients with advanced PD have more time with symptoms (‘off’ time) when they can’t control their body or do even the simple tasks like dress themselves. This has a detrimental emotional effect not just on the patients but also on carers, family members and those close to them.